new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one provider empowering you from Sample to Insight.
The Spring 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expand...
Researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in...
Easy assembly of Oxford Nanopore or PacBio reads and contig-polishing with high-quality Illumina rea...
Wednesday, March 25, hear from Dr. Anthony M Magliocco, CEO and Founder of Protean BioDiagnostics, a...
10.1.2 release (December 2019) Single-cell analysis: Improved expression overlay on tSNE/UMAP plot...
HGMD 2020.1 Release
QIAGEN Digital Insights Publication Roundup (Spring 2020)
De novo assembly of Oxford Nanopore MinION reads with QIAGEN CLC Genomics Workbench
LIVE WEBINAR: Closing the Precision Medicine Gap Using Whole Exome Sequencing
New features in the QIAGEN OmicSoft 10.1.2 release
Targeted NGS panels and optimized analysis and interpretation tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
QIAGEN maintains the world’s largest, expert-curated knowledgebase of up-to-date evidence for discovery research, clinical test interpretation and pharmaceutical development.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients